Synergistic co-delivery of doxorubicin and melittin using functionalized magnetic nanoparticles for cancer treatment: loading and in vitro release study by LC

Synergistic co-delivery of doxorubicin and melittin using functionalized magnetic nanoparticles for cancer treatment: loading and in vitro release study by LC–MS/MS

Published:2018-11-12 Issue:sup3 Volume:46 Page:S1226-S1235
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Hematyar Marjan¹,Soleimani Majid¹^ORCID,Es-haghi Ali²,Rezaei Mokarram Ali³

Affiliation:

1. Department of Chemistry, Imam Khomeini International University (IKIU), Qazvin, Iran;

2. Department of Physico Chemistry, Razi Vaccine & Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran;

3. Department of QA, Razi Vaccine & Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran

Funder

Research Council of Imam Khomeini International University

Research Council of Razi Vaccine and Research Institute

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2018.1536063

Reference45 articles.

1. Apoptosis: A Review of Programmed Cell Death